Arvinas Inc
Arvinas Inc logo
ARVN

Arvinas Inc (ARVN)

$36.541.72%

Market is closed
– opens on 8 PM, 12 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$36.5
Day's Range
$37.37
$34.9
52-Week Range
$83.4
1 month return19.73%
3 month return26.92%
1 year return45.63%
5 year return127.66%

Company Information

Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC® protein degraders against validated and "undruggable" targets, the company has two clinical-stage programs: ARV-110 for the treatment of men with metastatic castrate-resistant prostate cancer; and ARV-471 for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer.
OrganizationArvinas Inc
Employees280
CEODr. John G. Houston Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 13 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 13 Wall street analysts offering stock ratings for Arvinas Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 129.61%

Current

$36.54

Target

$83.9

Recommendation Trend

Based on 13 analyst

Current1M Ago3M Ago
Buy
13
23
22
Hold
0
4
4
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
2.0B
Book Value
$11.68
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-4.18
Wall Street Target Price
83.9

Valuation

Trailing PE0.0
Forward PE17.7
Price/Book (mrq)
3.54
Enterprise Value
938.3M
Enterprise Value/Revenue
8.37
Enterprise Value/Ebitda
-3.95

Technicals

Beta
1.8
50 Day MA
44.48
200 Day MA
50.38

Institutional Holdings

FMR Inc

13.83%

Avidity Partners Management LP

8.16%

Vanguard Group Inc

7.85%

BlackRock Inc

6.96%

EcoR1 Capital, LLC

5.87%

Bellevue Group AG

4.12%

Discover more

Frequently Asked Questions

What is Arvinas Inc share price today?

Can Indians buy Arvinas Inc shares?

How can I buy Arvinas Inc shares from India?

Can Fractional shares of Arvinas Inc be purchased?

What are the documents required to start investing in Arvinas Inc stocks?

What are today’s High and Low prices of Arvinas Inc?

What are today’s traded volumes of Arvinas Inc?

What is today’s market capitalisation of Arvinas Inc?

What is the 52 Week High and Low Range of Arvinas Inc?

How much percentage Arvinas Inc is down from its 52 Week High?

How much percentage Arvinas Inc is up from its 52 Week low?

What are the historical returns of Arvinas Inc?

Who is the Chief Executive Officer (CEO) of Arvinas Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*